Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Arimidex anastrozole: Marketed to treat post-menopausal hormone-receptor positive breast cancer and advanced breast cancer that has progressed following tamoxif

AZN said that the Technology Assessment Working Group of the American Society

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE